These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17457298)

  • 1. [Pharmacological treatment of generalized anxiety disorders: rationale and limitations].
    Boulenger JP; Capdevielle D
    Encephale; 2007; 33(1):84-94. PubMed ID: 17457298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice].
    Pélissolo A; Maniere F; Boutges B; Allouche M; Richard-Berthe C; Corruble E
    Encephale; 2007; 33(1):32-8. PubMed ID: 17457292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyzine for generalised anxiety disorder.
    Guaiana G; Barbui C; Cipriani A
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting pharmacotherapy for generalized anxiety disorder.
    Goodman WK
    J Clin Psychiatry; 2004; 65 Suppl 13():8-13. PubMed ID: 15384931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for generalized anxiety disorder.
    Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
    Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.
    Starcevic V
    Expert Rev Neurother; 2014 Nov; 14(11):1275-86. PubMed ID: 25242262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of generalized anxiety disorder.
    Roerig JL
    J Am Pharm Assoc (Wash); 1999; 39(6):811-21; quiz 877-9. PubMed ID: 10609447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of generalized anxiety disorders].
    Etchegaray M; Hardy P
    Presse Med; 2008 May; 37(5 Pt 2):859-66. PubMed ID: 18378113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment of generalized anxiety disorder.
    Brawman-Mintzer O
    Psychiatr Clin North Am; 2001 Mar; 24(1):119-37. PubMed ID: 11225503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug treatment of anxiety disorders].
    Corfdir C; Pelissolo A
    Rev Prat; 2019 Nov; 69(9):981-984. PubMed ID: 32237616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalised anxiety disorder: treatment options.
    Sramek JJ; Zarotsky V; Cutler NR
    Drugs; 2002; 62(11):1635-48. PubMed ID: 12109925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.
    Bandelow B; Zohar J; Hollander E; Kasper S; Möller HJ;
    World J Biol Psychiatry; 2002 Oct; 3(4):171-99. PubMed ID: 12516310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based pharmacotherapy of Generalized Anxiety Disorder.
    Baldwin DS; Polkinghorn C
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):293-302. PubMed ID: 15576000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.